|
HS Code |
740022 |
| Product Name | 5-Bromo-8-Chloroisoquinoline |
| Cas Number | 884494-97-1 |
| Molecular Formula | C9H5BrClN |
| Molecular Weight | 242.50 |
| Appearance | Solid, often light yellow to beige |
| Solubility | May be soluble in organic solvents like DMSO, dichloromethane |
| Purity | Usually >97% (for research applications) |
| Smiles | C1=CC2=C(C=CN2)C(=C1Br)Cl |
| Inchi | InChI=1S/C9H5BrClN/c10-7-2-1-3-8-6(7)4-5-12-9(8)11 |
| Synonym | 5-Bromo-8-chloro-isoquinoline |
| Storage Conditions | Store in cool, dry place, away from light |
| Usage | Pharmaceutical and chemical research intermediate |
| Hazard Statements | May cause skin and eye irritation |
As an accredited 5-Bromo-8-Chloroisoquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-8-Chloroisoquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Specialty chemicals make up the backbone of breakthroughs in pharmaceuticals and advanced materials, and among these, 5-Bromo-8-Chloroisoquinoline stands out for its consistency and versatility. When I first came across this compound in the lab, I remember struggling to find a variant that didn’t give me headaches with impurities or unpredictability. Now, years down the road, it is surprising how a compound with such a modest formula can quietly shape research in ways that major headlines rarely catch.
5-Bromo-8-Chloroisoquinoline has the chemical formula C9H5BrClN. Its structure brings together both bromine and chlorine substituents on the isoquinoline ring, which makes it more than a mere starting material. For chemists, this positioning unlocks reactivity options not found with simple isoquinolines. Unlike the plain parent compound or options with single halogenation, dual substitution translates into a greater set of transformation pathways. Its melting point commonly registers around 95-98 °C, which helps when planning purification steps, especially if you’ve ever cursed at a tricky separation.
Through years in the synthesis trenches, I’ve come to value reliable purity above all else. Standard batches of 5-Bromo-8-Chloroisoquinoline available on the market typically reach purity of 97% or higher, which saves time otherwise lost to reworking or extra filtration. The compound falls into the pale yellow to light brown crystalline solid category—a seemingly small detail, but it sets trace-level impurities in sharp relief during visual checks. Each time I open a fresh vial, it’s pretty clear if something doesn’t match expectations, which cuts back on surprises during scale-up.
Most of my exposure to 5-Bromo-8-Chloroisoquinoline started with drug molecule assembly. Its role as an intermediate makes it a favorite for medicinal chemists who want to introduce new scaffolds into drug candidates. When you see a substitution pattern like this, you know you can use cross-coupling chemistry--for example the Suzuki and Buchwald-Hartwig reactions. Because the molecule has both a bromine and a chlorine atom, researchers can tackle selective activation, allowing multi-step functionalization without juggling extra protecting groups. There aren’t many isoquinoline derivatives that deliver this sort of flexibility.
This extra handle on selectivity translates into less waste, which benefits both the cost structure and the environmental footprint of a project. My lab once compared similar workflows with monosubstituted analogs and found we used twice as many purification resources for only a marginal improvement in yield. The dual halogenation pattern on 5-Bromo-8-Chloroisoquinoline allowed us to skip two steps. Over the course of a year, that adds up to serious savings on reagents and waste disposal.
Research groups across Europe and Asia have also leaned on this compound as a springboard for new fluorescent probes. While the technical journals tend to dwell on the specifics of each reaction, I appreciate how accessible this core can be for students learning transition metal-catalyzed couplings for the first time. They gain an appreciation for stereo- and regiochemistry faster, because the selectivity built into the molecule rewards careful planning.
There’s no one-size-fits-all in synthetic organic chemistry. The more basic isoquinolines and their brominated or chlorinated cousins serve some purposes well, but run into limits in more complex settings. For instance, single halogen substitutions don’t offer the same degree of modularity in late-stage functionalization. In one project, we ran a head-to-head scale-up using 8-chloroisoquinoline versus the dual-substituted variant. Cleanup after coupling was smoother and final yields significantly higher with 5-Bromo-8-Chloroisoquinoline, so much so that the extra cost of the raw material felt trivial.
A common competitor in the lab is 5-bromoisoquinoline. I found reaction rates sometimes slower, and the regioselectivity less predictable, especially in Suzuki couplings. The extra halogen atom on the 8-position in 5-Bromo-8-Chloroisoquinoline stabilizes intermediates and nudges the chemistry toward a single main product, so there’s less time spent troubleshooting byproducts and more bandwidth for meaningful work.
In contrast, using fully unsubstituted isoquinoline provides no halogen handles for the coupling logic needed in complex synthesis. We had more than one early-career scientist forget this difference, only to backtrack entire research weeks due to a misread bottle. Modern teams lean toward building blocks like 5-Bromo-8-Chloroisoquinoline specifically to sidestep those dead ends.
Many lessons in chemistry only stick after a painful round of troubleshooting. One of the clearest came during a late-night synthesis run, where a supplier switch sent us a batch with higher residual solvents. Contaminated 5-Bromo-8-Chloroisoquinoline not only dragged our coupling reactions off course, but also risked introducing trace residues downstream. From that day forward, I came to see every purchase as an investment in data integrity.
Trusted suppliers often back their lots with certificate of analysis supporting their stated purity. When that paperwork matches the real-life crystal appearance and thin-layer chromatography profile, I breathe a little easier. Slight differences in quality between vendors can have big effects in critical reactions—especially for API research, where patient safety comes before everything. If you’re planning scale-up to multi-gram or kilogram ranges, trace metals and residual moisture profiles assessed by ICP-MS or Karl Fischer titration take a front seat.
Surveys among medicinal chemists highlight how often delays come down to inconsistent starting material quality. Whole synthesis campaigns risk derailment when early intermediates vary between lots. That’s one more reason this compound’s widespread use across reputable research programs stands out. Research groups aren’t shy with feedback, and recurring purchases often signal a product’s real-life dependability.
Every chemical brings potential hazards if handled carelessly. With 5-Bromo-8-Chloroisoquinoline, proper ventilation and direct fume hood handling are non-negotiable. Its dust can irritate skin and respiratory passages—firsthand experience handling a clumsy spill reminded me that gloves and fitted goggles aren’t optional, even during routine transfers. Material safety data available from responsible suppliers outlines best practices. Disposal always routes through lab waste collection, never down the drain or regular trash, to avoid both legal and environmental headaches.
Some researchers press for greener synthesis alternatives, exploring microwave-assisted couplings and aqueous-phase procedures with this building block. These tweaks can shave down solvent use, cut reaction times, or both. From a broader industry stance, efforts to reduce waste and hazardous reagents gain traction each year, with specialty chemicals seeing tighter regulatory scrutiny. Projects that consider the full life-cycle impact—from raw material extraction to disposal—are more likely to achieve both technical and environmental goals.
After testing countless batches, a few consistent tricks have made handling 5-Bromo-8-Chloroisoquinoline smoother. The compound dissolves well in DMF and DMSO, but can precipitate stubbornly from less polar solvents. Pre-drying solvents and warming moderately avoids frustrating re-precipitation. During stock preparations, I’ve learned that storing the compound tightly sealed below room temperature preserves color and purity much longer. Silica gel flash column chromatography handles the clear-cut separation of byproducts, but overloaded columns introduce tailing, so it pays to limit sample size per run.
Careful weighing and hygroscopicity checks prevent moisture from creeping into reaction mixtures. Because some newer researchers forget this step, combination with moisture-sensitive reagents occasionally backfires. Those who record detailed lab notes on supplier, batch, and storage conditions save time in troubleshooting down the line. I’ve learned these hard rules through missed deadlines, which is why they’re worth sharing.
Collaborative projects between R&D teams and scale-up facilities benefit from jointly reviewing procedures using this compound. What works great at bench scale sometimes introduces headaches when heat transfer or mechanical stirring differs at larger volumes. Simple pilot runs, combined with thermal gravimetric analysis, usually spot any surprises in advance. Working with a team that values feedback lets issues get flagged early, be it accidental foaming or gradated color changes that hint at impurities.
Few molecules see regular use across as many research verticals as 5-Bromo-8-Chloroisoquinoline. Labs experimenting with kinase inhibitors, anti-inflammatories, or fluorescent tracers buy it year after year, not because every project ends in a final drug product, but because exploration relies on things going right the first time. In government or industry labs, limited grant cycles or corporate timelines mean nobody wants a multi-week delay caused by starting material hiccups. Years of cross-team projects taught me that success often rides on foundation decisions, like picking the right intermediate for the right stage.
Experienced chemists chase reliability, but newer team members may gravitate toward cost savings at the expense of long-term headaches. Mentorship shines brightest when the more seasoned voice can share war stories on why trusted intermediates like this compound punch above their weight class. Each failed run or back-ordered starting material is a learning moment, shaping next year’s project plans and future grants.
No specialty chemical solves every problem. Access to 5-Bromo-8-Chloroisoquinoline still shows gaps in some markets, where shipping and import barriers add both cost and complexity. Customs backlogs and paperwork can shut down synthesis efforts for weeks, especially in overseas R&D hubs. Building responsive, transparent supply networks for specialty reagents makes a difference to teams racing competitors or publication deadlines. Some labs, finding dedicated suppliers unreliable, have pivoted to in-house synthesis, though that often means re-investing in purification equipment and sacrificing time that could go to discovery work.
Intellectual property considerations enter into the discussion with derivatives. Certain late-stage transformations using this intermediate are protected, which makes open-access collaborations more complicated. Students, postdocs, and principal investigators now balance not only reaction design but also the freedom to operate. It’s a reminder that chemistry isn't just about molecules, but also who has the right to use them where and when.
Long-term, expanding regional suppliers and encouraging open communication across research groups can meet access challenges head-on. By pooling knowledge about reliable vendors, purification tricks, and alternative synthetic routes, research communities keep costs in check and quality high. Peer-reviewed industry consortia may help drive standards forward, with reliable assessment of batch purity and batch traceability.
Another strategy comes in pre-competitive partnerships. Joint procurement models, where several research teams group orders to secure better pricing and more consistent supply, have begun to take root in certain academic consortia. This helps de-risk scaling up or moving from bench to pilot plant. Companies making advances in greener synthesis and safer handling protocols share these methods at conferences and through pre-print repositories, accelerating best practice adoption.
Online communities, from specialized chemistry forums to Slack groups for syn-org researchers, have proved surprisingly potent in troubleshooting supplier and handling issues in real time. In the past, graduate students might struggle months to solve a purification bottleneck. Now, collective experience speeds up experimentation by boosting both confidence and results. All these steps strengthen the chain from initial purchase to final application, benefiting those pushing science forward.
For labs prioritizing environmental footprint, every step in a chemical’s journey offers room for improvement. Sourcing from suppliers who disclose not just purity metrics but also the full environmental and safety profile of their processes promotes better-informed decisions. Support for accreditation initiatives, which assess the full chain from feedstock to shipping, pushes the industry toward greater accountability. Teams winning grants often find that a track record of responsible chemicals management strengthens their proposals, creating a virtuous cycle.
Collaboration in developing new workup and purification methods also reflects this growing accountability. Pushing for milder, more selective couplings using 5-Bromo-8-Chloroisoquinoline shrinks waste and cuts cost. Open-access metrics for solvent use, yield, and safety foster a culture where discovery sits comfortably alongside sustainability. Even the most ambitious R&D projects can gain by integrating these lessons early.
In the final analysis, 5-Bromo-8-Chloroisoquinoline may not garner headline attention, but it stays in the toolkit of researchers who understand the link between smart planning and impactful science. As somebody who has seen discovery sprints grind to a halt thanks to unreliable intermediates, I would say consistent access to this compound supports morale, keeps projects on track, and preserves the resources needed for genuine innovation. With each lot delivered and each successful coupling, the foundation for drug discovery and materials science only grows stronger.
While research will always chase new horizons, it’s the bedrock of thoughtful decision-making that lets those leaps happen. For myself and many peers, 5-Bromo-8-Chloroisoquinoline remains a quiet testament to the power of reliable chemistry. Its value lies not only in the transformations it enables, but in the continuity and confidence it brings to the long-term work of scientific discovery.